Fifteen Connecticut companies made the 2025 Fortune 500 list of the largest U.S. corporations, which was announced Monday-- a sign of stability in the state's corporate sector. Bloomfield- ...

Regeneron licensed a weight loss drug and revealed study data for a pair of muscle-preserving medicines. Elsewhere, two neuroscience biotechs cut deals and Bluebird officially went private.

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...